
Cerebral Therapeutics
A Clinical-stage pharmaceutical company dedicated to improving the lives of patients living with uncontrolled neurological diseases, with an initial focus on refractory epilepsy.
Employees
Enterprise value
$160—240m
Authorizing premium user...